Glaucoma laser from Quantel Medical cleared by FDA

Ophthalmic ultrasound and laser device maker Quantel Medical (Clermont-Ferrand, France) has received FDA approval for its Solutis glaucoma laser. The approval follows the expiration of a patent issued to Massachusetts General Hospital (Boston, MA), which restricted the company and several other laser manufacturers from marketing selective laser trabeculoplasty (SLT) technology within the U.S. The company has been providing SLT technology to customers outside the U.S. since 2007.

Related: Novel ophthalmic imaging with adaptive optics, confocal imaging, and OCT

Related: Laser cataract surgery: Clearly advanced

SLT is a first-line and adjunct therapy option for reducing intraocular pressure (IOP) in glaucoma patients. The noninvasive procedure delivers targeted laser energy, inducing a regenerative response at the cellular level. Due to the laser energy’s gentle application, the treatment is repeatable and not associated with the ocular and systemic side effects or compliance issues commonly linked to glaucoma drugs.

The Solutis laser's design is adaptable to a physician's current slit lamp, eliminating the need for dedicated space and lowering end-user cost. It is also transportable from room to room or office to office, and includes storage accessories when not in use.

-----

Follow us on Twitter, 'like' us on Facebook, and join our group on LinkedIn

Subscribe now to BioOptics World magazine; it's free!

 

POST A COMMENT

Related Articles

Abbott, Carl Zeiss Meditec enter distribution agreement for laser cataract surgery product portfolio

Abbott Medical Optics (Santa Ana, CA) and Carl Zeiss Meditec (Jena, Germany) have entered into a nonexclusive agreement in which Abbott will offer each company's suite of laser cataract surgery pro...

Report forecasts ophthalmology diagnostic, monitoring equipment market to be worth $9.5M by 2018

The ophthalmology devices market is expected to grow at a compound annual growth rate (CAGR) of 6.8 percent to reach $9,466.7 million by 2018, according to market research firm Markets & Markets.

Jenoptik receives order worth $5.1M for production of medical lasers

Jenoptik's Lasers & Material Processing Division has received an order worth $5.1 million (€4 million) from a well-known medical technology manufacturer in Germany.

Bioptigen awarded NEI grants worth $1.72M for development of intraoperative OCT

The National Eye Institute (NEI) has allocated a total of $1.72 million in grants to Bioptigen for development of microscope-integrated intraoperative optical coherence tomography (OCT) technology.

BLOGS

Optogenetics among photonics techniques highlighted at Neuroscience 2014

Optogenetics among photonics techniques highlighted at Neuroscience 2014

Technology in general, and optogenetics in particular, is a focus here at Neuroscience 2015, wher...
BioOptics World editor-in-chief Barbara Goode

What is biophotonics?

At BioOptics World, our focus is photonics (including optics) for life sciences—that is, biophoto...

Nobel Prize honors super-resolution optical microscopy

"This year's prize is about how the optical microscope became a nanoscope," said Staffa...

Most Popular Articles


CONNECT WITH US

            

Twitter- BioOptics World

Copyright © 2007-2014. PennWell Corporation, Tulsa, OK. All Rights Reserved.PRIVACY POLICY | TERMS AND CONDITIONS